Harbin Medisan Pharmaceutical Co (SZSE:002900) Short-Term Debt : ¥430 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Harbin Medisan Pharmaceutical Co Short-Term Debt?

Harbin Medisan Pharmaceutical Co's Short-Term Debt for the quarter that ended in Mar. 2024 was ¥430 Mil.

Harbin Medisan Pharmaceutical Co's quarterly Short-Term Debt increased from Sep. 2023 (¥275 Mil) to Dec. 2023 (¥275 Mil) and increased from Dec. 2023 (¥275 Mil) to Mar. 2024 (¥430 Mil).

Harbin Medisan Pharmaceutical Co's annual Short-Term Debt declined from Dec. 2021 (¥270 Mil) to Dec. 2022 (¥220 Mil) but then increased from Dec. 2022 (¥220 Mil) to Dec. 2023 (¥275 Mil).

Harbin Medisan Pharmaceutical Co Short-Term Debt Historical Data

The historical data trend for Harbin Medisan Pharmaceutical Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Medisan Pharmaceutical Co Short-Term Debt Chart

Harbin Medisan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

180.00

269.78

270.28

220.22

275.27

Harbin Medisan Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															270.26	265.19	275.23	275.27	430.36

Harbin Medisan Pharmaceutical Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Harbin Medisan Pharmaceutical Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Harbin Medisan Pharmaceutical Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Medisan Pharmaceutical Co (SZSE:002900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Medisan Pharmaceutical Co Ltd (SZSE:002900) » Definitions » Short-Term Debt

Traded in Other Exchanges

N/A

Address

Beijing Road, Limin Development Zone, Heilongjiang Province, Harbin, CHN, 150025

Website

http://www.medisan.com.cn

Harbin Medisan Pharmaceutical Co Ltd is the pharmaceutical manufacturing company. It is engaged in the research, development, manufacturing and sales of chemical preparations. The main products are oxiracetam injection, mirtazapine tablets, valsartan dispersible tablets, injection brain drugs such as protein hydrolysate, glucose injection and sodium chloride injection. The company is also involved in research, development, production and sales of medical devices.

Executives

Fan Qing Ji	Executives
Zhao Qing Fu	Directors, Directors, and Executives
Liang Yan Fei	Directors, executives
Yao Fa Xiang	Executives
Wang Ming Xin	Executives

Harbin Medisan Pharmaceutical Co (SZSE:002900) Headlines

No Headlines